Skip to content

Clinical study of remimazolam in anesthesia for upper gastrointestinal endoscopic surgery

Clinical study of remimazolam in anesthesia for upper gastrointestinal endoscopic surgery

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062535
Enrollment
Unknown
Registered
2022-08-11
Start date
2022-08-15
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthesia for upper gastrointestinal endoscopic surgery

Interventions

Remimazolam group:anesthetized with remimazolam
Remimazolam+ Alfentanil group:anesthetized with remimazolam and Alfentanil

Sponsors

The First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients who need upper gastrointestinal endoscopy under general anesthesia, Asai ~ II, aged 18 ~ 60 years, BMI 20 ~ 25, are ethical. The patients are willing to take the test and sign the informed consent.

Exclusion criteria

Exclusion criteria: Chronic lung disease or air breathing SpO2 < 95, moderate to severe drinking, emergency surgery, clinical or imaging evidence showing gastric obstruction, intestinal anatomical changes, high risk of bleeding, unstable circulation, estimated treatment time of more than 30 minutes, unable to give informed consent. Patients with cerebral infarction within 3 months before operation had mental illness. Identified / suspected abuse or long-term use of narcotic sedatives and analgesics; Those who are allergic to conventional narcotic drugs or have contraindications; Patients who participated in other clinical studies at the same time.

Design outcomes

Primary

MeasureTime frame
Successful placement of gastroscope;

Countries

China

Contacts

Public ContactPengfei Yin
doctor123ypf@163.com+86 17816608033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026